These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1232004)

  • 1. Radioimmunoassay of norethindrone (17 alpha-ethynyl-17 beta-hydroxy-4-estren-3-one) and ethynyl-estradiol (17 alpha-ethynyl-1,3,5, (10)-estratien-3, 17 beta-diol). Application to human plasma determination of norethindrone after oral administration of this steroid.
    Pasqualini JR; Castellet R; Portois MC; Hill JL; Kincl FA; Cortes-Prieto J
    Reproduccion; 1975; 2(3-4):197-205. PubMed ID: 1232004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of plasma ethinylestradiol in the presence of circulating norethindrone.
    Stanczyk FZ; Gale JA; Goebelsmann U; Nerenberg C; Matin S
    Contraception; 1980 Nov; 22(5):457-70. PubMed ID: 7471737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatization of norethindrone to ethinyl estradiol by human placental microsomes.
    Barbieri RL; Petro Z; Canick JA; Ryan KJ
    J Clin Endocrinol Metab; 1983 Aug; 57(2):299-303. PubMed ID: 6863477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogens. Contraceptive therapy].
    Sojo-Aranda I; Cortés-Gallegos V
    Ginecol Obstet Mex; 1995 Jan; 63():46-9. PubMed ID: 7896159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of norethisterone and ethinylestradiol in the gravid rat and in the feto-placental unit of rhesus monkeys following intragastric administration of norethisterone acetate in combination with ethinylestradiol. I. Direct determinations.
    Täuber U; Hümpel M
    Arzneimittelforschung; 1984; 34(4):440-6. PubMed ID: 6540102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
    Joshi JV; Sankolli GM; Shah RS; Joshi UM
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):192-5. PubMed ID: 3086241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat.
    Yasuda K; Johnston JM
    Endocrinology; 1992 Feb; 130(2):708-16. PubMed ID: 1733719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiles of endogenous and ethynyl steroids in plasma and urine from women during administration of oral contraceptives.
    Sahlberg BL; Landgren BM; Axelson M
    J Steroid Biochem; 1987 May; 26(5):609-17. PubMed ID: 3586677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norethindrone antisera: anomalous cross-reactivities with use of 3H-tetrahydro-reduced norethindrone as radioligand.
    Watanabe H; Menzies JA; Jordan N; Loo JC
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):513-6. PubMed ID: 6635332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of ethynyl oestradiol and norethindrone after oral administration to women.
    Pasqualini JR; Castellet R; Portois MC; Hill JL; Kincl FA
    J Reprod Fertil; 1977 Mar; 49(2):189-93. PubMed ID: 850209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
    Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
    Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norethisterone and ethinyl estradiol kinetics during dapsone therapy.
    Joshi JV; Maitra A; Sankolli G; Bhatki S; Joshi UM
    J Assoc Physicians India; 1984 Feb; 32(2):191-3. PubMed ID: 6746515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of norethindrone: peripheral plasma levels after oral administration to humans and rhesus monkeys.
    Nygren KG; Lindberg P; Martinsson K; Bosu WT; Johansson ED
    Contraception; 1974 Mar; 9(3):265-78. PubMed ID: 4442276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamics of synthetic estrogens. Review article].
    Sojo-Aranda I; Cortés-Gallegos V
    Ginecol Obstet Mex; 1990 Oct; 58():277-83. PubMed ID: 2292429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogenic actions of norethisterone and its A-ring reduced metabolites. Induction of in vitro uterine sensitivity to serotonin.
    Oropeza MV; Campos MG; Lemus AE; Garciá G; Pérez-Palacios G; Ponce-Monter H
    Arch Med Res; 1994; 25(3):307-10. PubMed ID: 7803979
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.